as on September 18, 2025 at 3:19 pm IST
Market Cap
₹356.65 Cr
Return on Equity (ROE)
4.99
PE Ratio (TTM)
48.28
Return on capital employed (ROCE)
6.37
Industry PE ratio
42.21
Beta (LTM)
1.1
P/B Ratio
2.67
Dividend Yield
0PEG Ratio
9.43
Quarterly Earnings Growth YOY
-22.48
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on September 18, 2025 at 3:19 pm IST
Lyka Labs in the last 5 years
Lowest (-164.66x)
September 10, 2018
Industry (42.21x)
September 17, 2025
Today (48.28x)
September 17, 2025
Highest (56.13x)
July 31, 2025
Today’s Price to Earnings Ratio: 48.28x
Compare market cap, revenue, PE, and other key metrics of Lyka Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 356.65 | 84.64% | 0.64 | 8 | 134 | |
NA | 1,619.47 | 271.08% | 0.00 | 55 | 268 | |
NA | 252.08 | -0.18% | 0.00 | 9 | 162 | |
NA | 33.20 | 3.16% | 0.00 | 1 | 86 | |
NA | 12.75 | -4.85% | 0.00 | -3 | 28 |
Search interest for Lyka Labs Ltd Stock has increased by 16% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:16% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Lyka Labs.
Lyka Labs Ltd’s net profit fell -35.42% since last year same period to ₹0.93Cr in the Q1 2025-2026. On a quarterly growth basis, Lyka Labs Ltd has generated -47.46% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 40.94% to 41.01% in Jun 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 166.4%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 45.3%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 58.16% of holdings in Jun 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, 2.7 Cr → 0.93 Cr (in ₹), with an average decrease of 41.0% per quarter
Price Dip
In the last 3 months, LYKALABS stock has moved down by -12.5%
Revenue Fall
Revenue is down for the last 4 quarters, 41.18 Cr → 33.66 Cr (in ₹), with an average decrease of 6.2% per quarter
FII Holding Down
Foreign Institutions have decreased holdings from 0.23% to 0.16% in Jun 2025 quarter
Organisation | Lyka Labs Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | KUNAL NARENDRA GANDHI |
E-voting on shares | Click here to vote |
Lyka Labs share price today stands at ₹100 as on at the close of the market. Lyka Labs share today touched a day high of ₹100.7 and a low of ₹99.11.
Lyka Labs touched a 52 week high of ₹176.59 and a 52 week low of ₹96.71. Lyka Labs share price today i.e. is closed at ₹100, which is -43.37% down from its 52 week high and 3.40% up from its 52 week low.
Lyka Labs market capitalisation is ₹356.65 Cr as on .
To buy Lyka Labs shares, you need to follow these steps:
Lyka Labs trading volume is 15.59K as on . This means that 15.59K shares of Lyka Labs were bought and sold on the stock market during today's trading session.